A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Download in electronic PDF format for $75
Abstract: Pain is extremely common in the U.S. It is estimated that 116 million Americans suffer from chronic pain. Narcotics and opioid medications are heavily relied upon for the treatment of pain. Currently, there is an epidemic of opioid abuse and misuse in the U.S. and alternative methods for the treatment of pain are required. Topical compounded pain creams are thought to be one such alternative. The purpose of this study was to establish a baseline regarding the beliefs of community physicians on the safety and efficacy of these compounds. A survey was sent to practicing physicians in the U.S. regarding their prescribing behaviors for topical compounds, as well as their beliefs about the efficacy and safety of these medications. Eleven prescribing practitioners participated in this survey with a response rate of 78%. The results were compiled with basic statistical work (Excel). This survey demonstrated that at the time of the study, topical compound creams for the treatment of pain were commonly used in clinical practice; these creams were used for musculoskeletal pain and for neuropathic pain. It was also determined that the vast majority of practicing prescribers felt that compounded pain creams were more efficacious than mass-produced, U.S. Food and Drug Administration-approved creams marketed by large multi-national pharmaceutical companies. Most of the respondents felt that these compounds allowed them to reduce their narcotic prescriptions overall. In addition, the results demonstrated that the prescribers felt these compounds were safe for their patients. In this small survey of practicing prescribing providers regarding the use of topical compounds, we found that these medications were not only effective but also safe.
Related Keywords:
topical preparations, pain relief, pain control, analgesia, analgesic, prescribers, drug safety, neuropathic pain, neuropathy, musculoskeletal pain, opioid abuse, alternative therapies
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Warner Meredith, Tuder Dmitry
|
May/Jun 2014
Pg. 182-188
|
Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
|
May/Jun 2010
Pg. 200-203
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Mar/Apr 2024
Pg. 100-109
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Jul/Aug 2014
Pg. 278-286
|
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance
Jones Marty
|
Jan/Feb 2002
Pg. 4-6
|
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
|
Mar/Apr 2016
Pg. 107-113
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Mar/Apr 2024
Pg. 111-116
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jul/Aug 2015
Pg. 295-300
|
Topical Treatment of Neuropathic Pain
Vadaurri Vince
|
May/Jun 2008
Pg. 182-190
|
Update on Managing Neuropathic Pain
McNulty Jack P, Muller George
|
May/Jun 2009
Pg. 182-190
|
Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Shawaqfeh Mohammad S, Harrington Catherine
|
Jan/Feb 2018
Pg. 19-24
|
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
|
Nov/Dec 2016
Pg. 517-520
|
NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 446-448
|
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Zugerman Jessie Jean M, Reed Thomas C
|
Nov/Dec 2007
Pg. 514-519
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
Mar/Apr 2024
Pg. 118-119
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
May/Jun 2009
Pg. 218-219
|
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications
Gilbert John A
|
Sep/Oct 2009
Pg. 400-403
|
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah, Agu Remigius U
|
Nov/Dec 2019
Pg. 496-503
|
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel, White Lyndell
|
Jul/Aug 2010
Pg. 310-314
|
Return to Top |